Improving HIV-2 Detection by a Combination of Serological and Nucleic Acid Amplification Test Assays

ABSTRACT The ability to detect HIV-2 and to discriminate between HIV-1 and HIV-2 infections was evaluated in 46 serum samples from Guinea-Bissau (GB) and Guinea-Conakry (GC) using serological tests and commercial (HIV-1) and in-house (HIV-2) real-time PCR assays. Samples were first identified as HIV-2 positive by Genie I/II assay in GB and GC. HIV positivity was detected in 44 of 46 samples by all screening and confirmatory assays. A diagnostic strategy based on Inno-LIA and HIV-1/2 RNA detection assays allowed accurate discrimination between HIV-1 and HIV-2 in 84% of single infections and confirmed 32% of double infections. In samples with double reactivity in the Inno-LIA test and no detection of both genomes, cross-reactivity likely hampered the identification of true double infections. In conclusion, the implementation of a diagnostic strategy, based on multiple specific serological tests and highly sensitive quantitative PCR assays, is recommended to ensure accurate HIV-2 diagnosis and appropriate therapy for individuals from areas in which the virus is endemic.

[1]  F. Antunes,et al.  20 years of HIV-2 infection in Portugal: trends and changes in epidemiology. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  S. Andersson,et al.  Performance of three automated fourth‐generation combined HIV antigen/antibody assays in large‐scale screening of blood donors and clinical samples , 2009, Transfusion medicine.

[3]  J. Parry,et al.  Improvement in the performance of HIV screening kits , 2008, Transfusion medicine.

[4]  F. Baldanti,et al.  Screening and Management of HIV-2-Infected Individuals in Northern Italy. , 2008, AIDS patient care and STDs.

[5]  J. Desenclos,et al.  Long-term persistence of memory B cells specific for hepatitis B surface antigen in HIV-1-infected patients , 2007, AIDS.

[6]  J. Garson,et al.  Development and evaluation of a real-time RT-PCR assay for quantification of cell-free human immunodeficiency virus type 2 using a Brome Mosaic Virus internal control. , 2006, Journal of virological methods.

[7]  S. Dougan,et al.  Diagnoses of HIV-1 and HIV-2 in England, Wales, and Northern Ireland associated with west Africa , 2005, Sexually Transmitted Infections.

[8]  F. Brun-Vézinet,et al.  Polymorphism of the Human Immunodeficiency Virus Type 2 (HIV-2) Protease Gene and Selection of Drug Resistance Mutations in HIV-2-Infected Patients Treated with Protease Inhibitors , 2005, Journal of Clinical Microbiology.

[9]  F. Dabis,et al.  Field Evaluation of a Rapid Human Immunodeficiency Virus (HIV) Serial Serologic Testing Algorithm for Diagnosis and Differentiation of HIV Type 1 (HIV-1), HIV-2, and Dual HIV-1-HIV-2 Infections in West African Pregnant Women , 2004, Journal of Clinical Microbiology.

[10]  J. M. González,et al.  A fluorimetric method for the estimation of G+C mol% content in microorganisms by thermal denaturation temperature. , 2002, Environmental microbiology.

[11]  R. Doms,et al.  Human immunodeficiency virus type 2. , 2002, Journal of General Virology.

[12]  A. Berger,et al.  Multicenter Evaluation of a New Automated Fourth-Generation Human Immunodeficiency Virus Screening Assay with a Sensitive Antigen Detection Module and High Specificity , 2002, Journal of Clinical Microbiology.

[13]  Sudhir Kumar,et al.  MEGA2: molecular evolutionary genetics analysis software , 2001, Bioinform..

[14]  G. Schochetman,et al.  Seven Human Immunodeficiency Virus (HIV) Antigen-Antibody Combination Assays: Evaluation of HIV Seroconversion Sensitivity and Subtype Detection , 2001, Journal of Clinical Microbiology.

[15]  F. Brun-Vézinet,et al.  Variability of human immunodeficiency virus type 2 (hiv-2) infecting patients living in france. , 2001, Virology.

[16]  W. Heneine,et al.  Human immunodeficiency virus type 2 (HIV‐2) in Portugal: Clinical spectrum, circulating subtypes, virus isolation, and plasma viral load , 2000, Journal of medical virology.

[17]  F. Brun-Vézinet,et al.  Highly Sensitive Method for Amplification of Human Immunodeficiency Virus Type 2 DNA , 1998, Journal of Clinical Microbiology.

[18]  F. Dias,et al.  Field evaluation of alternative testing strategies for diagnosis and differentiation of HIV‐1 and HIV‐2 infections in an HIV‐1 and HIV‐2‐prevalent area , 1997, AIDS.

[19]  F. Brun-Vézinet,et al.  HIV-1 and HIV-2 AIDS in African patients living in Paris. , 1997, AIDS.

[20]  J. Thompson,et al.  CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. , 1994, Nucleic acids research.

[21]  H Hui,et al.  Genetic diversity of human immunodeficiency virus type 2: evidence for distinct sequence subtypes with differences in virus biology , 1994, Journal of virology.

[22]  H. Whittle,et al.  HIV type 2 proviral load measured by quantitative polymerase chain reaction correlates with CD4+ lymphopenia in HIV type 2-infected individuals. , 1994, AIDS research and human retroviruses.

[23]  F. Brun-Vézinet,et al.  Isolation of a new human retrovirus from West African patients with AIDS. , 1986, Science.

[24]  J. Allan,et al.  SEROLOGICAL EVIDENCE FOR VIRUS RELATED TO SIMIAN T-LYMPHOTROPIC RETROVIRUS III IN RESIDENTS OF WEST AFRICA , 1985, The Lancet.

[25]  D. Swofford.  PAUP*: Phylogenetic analysis using parsimony (*and other methods), Version 4.0b10 , 2002 .

[26]  T. A. Hall,et al.  BIOEDIT: A USER-FRIENDLY BIOLOGICAL SEQUENCE ALIGNMENT EDITOR AND ANALYSIS PROGRAM FOR WINDOWS 95/98/ NT , 1999 .